A new approach to tackling microbiological contaminants in cannabis.
Medicinal Genomics West Coast Field Application Scientist Kyle Boyar shows how DNA sequencing of both the cannabis microbiome and the conditions before and after culturing tell a tale of inaccurate methodology. Methods that are currently being employed by cannabis testing labs lead the industry astray and blind consumer and producers to the real hazards that could be present. This presentation will walk you through the data that shows this and the discoveries we’ve made along the way that will hopefully open discussions for a fresh new perspective on how to tackle microbiological contaminants in cannabis.
©2024 MEDICINAL GENOMICS CORPS
Copyright all right reserved.
Signup to receive email updates on blog posts, podcasts, webinars, new products, and more!
Join us at the CannMed 24 Innovation and Investment Summit, an exclusive experience of discovery, development, and networking with innovators from around the world.